Suppr超能文献

[镓-67闪烁扫描术作为肝脏占位性病变鉴别诊断的辅助方法(作者译)]

[67-Galliumscintigraphy as an auxiliary method for differentiation of mass lesions of the liver (author's transl)].

作者信息

Blazek G, Mastnak C, Kahn P, Weiss W, Hanak H

出版信息

Wien Klin Wochenschr. 1975 Feb 7;87(3):77-81.

PMID:49132
Abstract

Liver scintigraphy with 67-Ga citrate and alphafetoprotein (afp) determinations in the serum were carried out in 84 patients with liver mass lesions in the preceding sulphur colloid scans. Among these patients 51 cases were histologically verfied and 33 patients were regarded as clinically-proven cases. Scanning was carried out 72 hours after the intravenous injection of 3 mC 67-Ga-citrate. Corresponding to the intensity of 67-Ga uptake within the former liver lesions 3 groups of 67-Ga scans were differentiated: Ga 0 (the lesion showed no Ga uptake), Ga plus (the Ga uptake within the lesion was equal to that of the surrounding liver tissue) and Ga plus plus (the Ga uptake within the former lesion exceeded the physiological Ga uptake in the normal liver tissue). The number of cases, results of Ga scintigraphy and afp examinations as well as histological, clinical and nuclear medical diagnosis were correlated. It was shown that Ga plus plus cases were strongly suspect of hepatoma, whereas in Ga 0 cases a diagnosis of hepatoma could be excluded. In patients with Ga plus further investigations have to be performed (repeated afp examinations, angiography of the coeliac artery), because cirrhotic regeneration nodules, metastases and necrotic hepatomata were all found within this group. According to our experience liver scanning with 67Ga represents a useful auxiliary examination in liver diagnosis. Ga citrate scintigraphy of the liver is indicated in all cases with mass lesions detected by the routine sulphur colloid scan and in all patients in whom there is clinical suspicion of hepatoma, inorder to differentiate the origin of the lesions. In 2 cases of hepatoma marked Ga uptake was observed at a time when the afp was still negative.

摘要

对84例先前经硫胶体扫描发现肝脏有占位性病变的患者进行了血清67镓枸橼酸盐肝脏闪烁扫描及甲胎蛋白(AFP)测定。其中51例经组织学证实,33例为临床确诊病例。静脉注射3毫居里67镓枸橼酸盐后72小时进行扫描。根据原肝脏病变内67镓摄取强度,将67镓扫描分为3组:Ga 0(病变无67镓摄取)、Ga +(病变内67镓摄取与周围肝组织相等)和Ga ++(原病变内67镓摄取超过正常肝组织的生理性67镓摄取)。对病例数、镓闪烁扫描结果、AFP检查结果以及组织学、临床和核医学诊断进行了相关性分析。结果显示,Ga ++病例高度怀疑为肝癌,而Ga 0病例可排除肝癌诊断。Ga +组患者需进一步检查(重复AFP检查、腹腔动脉造影),因为该组中发现了肝硬化再生结节、转移瘤和坏死性肝癌。根据我们的经验,67镓肝脏扫描是肝脏诊断中一项有用的辅助检查。对于所有经常规硫胶体扫描发现有占位性病变的病例以及所有临床怀疑肝癌的患者,均应进行肝脏枸橼酸镓闪烁扫描,以鉴别病变的来源。在2例肝癌病例中,当AFP仍为阴性时就观察到了明显的67镓摄取。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验